Gossamer Bio Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 18c
August 8, 2019 5:22 PM EDTGossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.74), $0.18 worse than the analyst estimate of ($0.56).
Over the last several months, we have made significant progress advancing our diversified development portfolio, with five clinical trials now active, said Sheila Gujrathi, M.D., Co-Founder and... More
